China · Delayed Price · Currency is CNY Honz Pharmaceutical Statistics
Total Valuation
SHE:300086 has a market cap or net worth of CNY 2.44 billion. The enterprise value is 2.87 billion.
| Market Cap | 2.44B |
| Enterprise Value | 2.87B |
Important Dates
The next confirmed earnings date is Monday, October 26, 2026.
| Earnings Date | Oct 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300086 has 455.12 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 455.12M |
| Shares Outstanding | 455.12M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 4.22% |
| Owned by Institutions (%) | 5.10% |
| Float | 334.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.46 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 3.06 |
| P/FCF Ratio | 96.30 |
| P/OCF Ratio | 56.00 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 113.24 |
Financial Position
The company has a current ratio of 0.46, with a Debt / Equity ratio of 0.48.
| Current Ratio | 0.46 |
| Quick Ratio | 0.11 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | n/a |
| Debt / FCF | 16.80 |
| Interest Coverage | -8.19 |
Financial Efficiency
Return on equity (ROE) is -21.27% and return on invested capital (ROIC) is -10.44%.
| Return on Equity (ROE) | -21.27% |
| Return on Assets (ROA) | -4.73% |
| Return on Invested Capital (ROIC) | -10.44% |
| Return on Capital Employed (ROCE) | -11.97% |
| Weighted Average Cost of Capital (WACC) | 5.33% |
| Revenue Per Employee | 701,041 |
| Profits Per Employee | -386,710 |
| Employee Count | 540 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 1.04 |
Taxes
| Income Tax | -14.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.61% in the last 52 weeks. The beta is 0.27, so SHE:300086's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -23.61% |
| 50-Day Moving Average | 6.39 |
| 200-Day Moving Average | 8.02 |
| Relative Strength Index (RSI) | 28.53 |
| Average Volume (20 Days) | 20,647,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300086 had revenue of CNY 378.56 million and -208.82 million in losses. Loss per share was -0.46.
| Revenue | 378.56M |
| Gross Profit | 203.63M |
| Operating Income | -136.97M |
| Pretax Income | -226.50M |
| Net Income | -208.82M |
| EBITDA | -78.42M |
| EBIT | -136.97M |
| Loss Per Share | -0.46 |
Balance Sheet
The company has 17.11 million in cash and 426.33 million in debt, with a net cash position of -409.22 million or -0.90 per share.
| Cash & Cash Equivalents | 17.11M |
| Total Debt | 426.33M |
| Net Cash | -409.22M |
| Net Cash Per Share | -0.90 |
| Equity (Book Value) | 887.65M |
| Book Value Per Share | 1.90 |
| Working Capital | -308.85M |
Cash Flow
In the last 12 months, operating cash flow was 43.65 million and capital expenditures -18.27 million, giving a free cash flow of 25.38 million.
| Operating Cash Flow | 43.65M |
| Capital Expenditures | -18.27M |
| Depreciation & Amortization | 58.55M |
| Net Borrowing | -37.32M |
| Free Cash Flow | 25.38M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 53.79%, with operating and profit margins of -36.18% and -55.16%.
| Gross Margin | 53.79% |
| Operating Margin | -36.18% |
| Pretax Margin | -59.83% |
| Profit Margin | -55.16% |
| EBITDA Margin | -20.71% |
| EBIT Margin | -36.18% |
| FCF Margin | 6.70% |
Dividends & Yields
SHE:300086 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.25% |
| Shareholder Yield | -0.25% |
| Earnings Yield | -8.54% |
| FCF Yield | 1.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 30, 2015. It was a forward split with a ratio of 1.5.
| Last Split Date | Sep 30, 2015 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300086 has an Altman Z-Score of 2.1 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.1 |
| Piotroski F-Score | 4 |